1905P - Advanced melanoma patients with high CD16+ macrophages have better response and survival to anti-PD-1 based immunotherapy

Autor: Lee, H. 1, Silva, I.D. 2, Batten, M. 2, Palendira, U. 1, Ferguson, A. 1, Carlino, M.S. 3, Menzies, A.M. 4, Saw, R.P. 5, Spillane, A.J. 5, Scolyer, R.A. 6, Long, G.V. 7, Wilmott, J. 2
Zdroj: In Annals of Oncology October 2019 30 Supplement 5:v771-v771
Databáze: ScienceDirect